Tue, 12 March 2013
Dr. Karen Reckamp: Will Our Gains in Targeted Therapies Be Generalizable to a Wider Range of Lung Cancers?
Dr. Karen Reckamp, City of Hope Cancer Center, provides her perspective on the likelihood that molecular oncology principles and targeted therapies will become more broadly applicable for patients with squamous and other lung cancer subtypes.
Direct download: GRACEcastUC-053_Lung-Video_Generalizability_of_Targeted_Rx_in_LC.m4v
Category:Lung-Cancer-Video -- posted at: 5:37pm PDT